Analyst Price Targets — SIBN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 12:24 pm | — | Truist Financial | $24.00 | $15.62 | TheFly | SI-Bone price target raised to $24 from $23 at Truist |
| December 18, 2025 2:15 pm | — | Truist Financial | $23.00 | $19.62 | TheFly | SI-Bone price target raised to $23 from $21 at Truist |
| December 17, 2025 12:28 pm | William Plovanic | Canaccord Genuity | $27.00 | $19.42 | TheFly | SI-Bone price target raised to $27 from $26 at Canaccord |
| December 16, 2025 11:46 am | David Saxon | Needham | $27.00 | $19.16 | StreetInsider | SI-BONE Inc. (SIBN) PT Raised to $27 at Needham, Added To Conviction List |
| December 2, 2025 11:36 am | — | Morgan Stanley | $23.00 | $18.87 | TheFly | SI-Bone price target raised to $23 from $20 at Morgan Stanley |
| October 15, 2025 12:46 pm | Richard Newitter | Truist Financial | $20.00 | $15.27 | TheFly | SI-Bone price target lowered to $20 from $22 at Truist |
| August 11, 2025 11:10 am | Ross Osborn | Cantor Fitzgerald | $25.00 | $15.68 | StreetInsider | Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN) |
| August 6, 2024 7:40 am | Samuel Brodovsky | Truist Financial | $18.00 | $14.04 | TheFly | SI-Bone price target lowered to $18 from $20 at Truist |
| August 6, 2024 7:16 am | David Saxon | Needham | $19.00 | $14.36 | StreetInsider | SI-BONE Inc. (SIBN) PT Lowered to $19 at Needham |
| March 28, 2024 6:40 am | Matt O'Brien | Piper Sandler | $25.00 | $15.82 | TheFly | SI-Bone initiated with an Overweight at Piper Sandler |
Latest News for SIBN
Si-Bone (SIBN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.11 per share a year ago.
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025
SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA. Management will be hosting a fireside chat on Monday, March 2, 2026, at 7:30 a.m.…
Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SIBN.
U.S. House Trading
No House trades found for SIBN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.